Epidermolysis bullosa acquisita treated with basiliximab, an interleukin-2 receptor antibody.
作者： Michael G. Haufs, Eckart Haneke
DOI: 10.1080/000155501750208353
关键词:
摘要:
medicaljournals.se参考文章(2)
Luca Borradori, James B Caldwell, Robert A Briggaman, Carlton E Burr, W Ray Gammon, William D James, Kim B Yancey, Passive Transfer of Autoantibodies From a Patient With Mutilating Epidermolysis Bullosa Acquisita Induces Specific Alterations in the Skin of Neonatal Mice Archives of Dermatology. ,vol. 131, pp. 590- 595 ,(1995) , 10.1001/ARCHDERM.1995.01690170092014
Peter L. Amlot, Eira Rawlings, Ossie N. Fernando, Peter J. Griffin, Gunther Heinrich, Max H. Schreier, Jean-Paul Castaigne, Richard Moore, Paul Sweny, Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation. Transplantation. ,vol. 60, pp. 748- 756 ,(1995) , 10.1097/00007890-199510150-00023